MainStay MacKay Convertible Bond’s selective mindset and steadfast investing style allow it to weather rough patches without major bruises, and a sensible, valuation-driven approach results in resilient performance.
NYLI MacKay Convertible Class A MCOAX
- NAV / 1-Day Return 19.50 / +0.26 %
- Total Assets 1.6 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.950%
- Distribution Fee Level Low
- Share Class Type Front Load
- Category Convertibles
- Investment Style Large Blend
- Min. Initial Investment 15,000
- Status Open
- TTM Yield 3.80%
- Turnover 33%
USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 10:32 PM GMT+0
Morningstar’s Analysis MCOAX
Will MCOAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings —
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
MainStay US Government Liquidity I | 4.75 | 73.9 Mil | Cash and Equivalents |
TransMedics Group Inc. 1.5% | 2.32 | 36.0 Mil | Corporate |
Lantheus Holdings Inc 2.625% | 2.31 | 35.9 Mil | Corporate |
Microchip Technology Incorporated 0.125% | 2.24 | 34.8 Mil | Corporate |
Tetra Tech Inc 2.25% | 2.08 | 32.3 Mil | Corporate |
Biomarin Pharmaceutical Inc. 1.25% | 1.82 | 28.3 Mil | Corporate |
Merit Medical Systems Inc. 3% | 1.77 | 27.5 Mil | Corporate |
Southwest Airlines Co. 1.25% | 1.76 | 27.4 Mil | Corporate |
Post Holdings Inc. 2.5% | 1.75 | 27.2 Mil | Corporate |
Ford Motor Company 0% | 1.74 | 27.1 Mil | Corporate |